GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Research & Development

Lombard Medical Technologies (LSE:LMT) Research & Development : £4.60 Mil (TTM As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Lombard Medical Technologies's Research & Development for the six months ended in Dec. 2012 was £4.60 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2012 was £4.60 Mil.

Lombard Medical Technologies Research & Development Historical Data

The historical data trend for Lombard Medical Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Research & Development Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.96 4.69 5.15 6.55 4.60

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.96 4.69 5.15 6.55 4.60

Lombard Medical Technologies Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2012 was £4.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lombard Medical Technologies  (LSE:LMT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Lombard Medical Technologies Research & Development Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Research & Development
Comparable Companies
XKLS:2127 HBIO XKRX:179290 UGHL ROCO:6612 ROCO:4150 XKRX:049180 HKSE:00876 OHEL:SILMA OSTO:ELOS B ISX:MARK IGAP XPAR:AMPLI ROCO:5312 BKK:TOG HKSE:01120 SSKN TSE:7775 ROCO:6499 OSTO:QLINEA
Traded in Other Exchanges
N/A
Address
Website
http://www.lombardmedical.com
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.